search
Back to results

Peri-implantitis - Reconstructive Surgical Therapy

Primary Purpose

Peri-Implantitis

Status
Active
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Open flap debridement
Bone replacement graft
Sponsored by
Göteborg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peri-Implantitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years
  • ≥1 implant (≥1 year of function) presenting with PPD ≥7 mm and BoP/Pus.
  • Confirmed bone loss ≥3 mm at same implant(s)

Exclusion Criteria:

  • Treated for peri-implantitis during previous 6 months
  • Intake of systemic or local antibiotics during previous 6 months
  • Systemic conditions affecting peri-implant tissues
  • Systemic conditions impeding surgical intervention

Sites / Locations

  • Department of Periodontology, Institute of Odontology

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control - Open flap debridement

Test - Bone replacement graft

Arm Description

The surgical procedure includes flap elevation, debridement of the peri-implant defect and decontamination of the implant surfaces using saline for irrigation. Flaps are replaced in their original position and carefully sutured. Patients are provided with post-surgical information and thereafter called in for regular follow-up visits.

The surgical procedure is identical to the control procedure with the exception of the application of the bone replacement graft. Following decontamination, Bio-Oss Collagen® is placed into the peri-implant bony defect. Flaps are carefully sutured and patients are provided with the same information and follow-up as patients in the control group.

Outcomes

Primary Outcome Measures

Treatment success (year 1)
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm recession of mucosal margin
Treatment success (year 3)
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm recession of mucosal margin
Treatment success (year 5)
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm

Secondary Outcome Measures

Radiographic outcomes
Defect fill and crestal bone support
Patient-reported outcomes
Patient-reported outcomes assessed by questionnaire and in relation to baseline

Full Information

First Posted
February 24, 2017
Last Updated
September 11, 2023
Sponsor
Göteborg University
Collaborators
Osteology Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03077061
Brief Title
Peri-implantitis - Reconstructive Surgical Therapy
Official Title
Reconstructive Surgical Therapy of Peri-implantitis-related Osseous Defects. A Multicenter Randomized Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
March 14, 2022 (Actual)
Study Completion Date
March 14, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Göteborg University
Collaborators
Osteology Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The project will evaluate the potential benefit of the use of bone replacement graft as an adjunct to surgical therapy of peri-implantitis. The project will be conducted as a two-armed randomized controlled clinical trial of 5-year duration in 7 clinical centers. 140 systemically healthy patients diagnosed with peri-implantitis will randomly assigned to be treated with or without bone replacement graft. Outcome measures include assessments of inflammation, probing depth, recession, radiological parameters and PROMs.
Detailed Description
Objective The overall objective of the project is to evaluate the clinical efficacy of the use of a bone substitute material in reconstructive surgical therapy of peri-implantitis-associated osseous defects. Hypothesis: The use of a bone substitute material in reconstructive therapy of peri-implantitis increases the likelihood to achieve treatment success. Relevance for clinical practice The project will provide significant contribution to the understanding of outcomes using reconstructive procedures in treatment of peri-implantitis. Study population, design and treatment procedures The project will be conducted as a two-armed randomized controlled clinical trial of 5-year duration in 7 clinical centers. 140 systemically healthy patients with implants ≥1 year in function and diagnosed with advanced peri-implantitis at ≥1 implants will be enrolled. Inclusion criteria Age ≥ 18 years ≥1 implant (≥1 year of function) presenting with PPD ≥7 mm and BoP/Pus. Confirmed bone loss ≥3 mm at same implant(s) Exclusion criteria Treated for peri-implantitis during previous 6 months Intake of systemic or local antibiotics during previous 6 months Systemic conditions affecting peri-implant tissues Systemic conditions impeding surgical intervention Surgical procedures Surgical procedures will be performed one month after a baseline examination and initiation of plaque control. Three days before surgery a 10-day systemic antibiotic regimen will be initiated. Full thickness flaps will be elevated and inflamed tissues will be removed. The implant surfaces will be cleaned with mini-gauze soaked in saline. The osseous defect should be ≤4 mm wide and >3 mm deep. The defect should in addition to the mesial and distal bone walls preferably exhibit at least a lingual or a buccal bone wall. The randomly assigned treatment strategy, stratified for smoking, will be revealed after debridement. Test procedure: The defect will be filled with Bio-Oss Collagen® and the flaps will be sutured to their previous position. Control procedure: Flaps will be sutured to their previous position. Sutures will be removed 2 weeks after treatment, followed by a 6-week control. Clinical examinations will be performed at 6, 12, 24, 36, 48 and 60 months after therapy. Maintenance therapy will be provided based on individual needs. Clinical assessments One calibrated examiner in each clinical center will perform the assessments. The following variables will be assessed at four sites around the implant: Plaque, probing pocket depth (PPD), bleeding on probing (BoP), probing attachment level (PAL) and recession (REC). Treatment success Treatment success will be defined as the absence of BoP/Pus, PPD ≤5 mm and ≤1 mm recession. Peri-implant sites showing BoP and PPD ≥6 mm at re-examination will be scheduled for further treatment. Patient-related outcome variables will be assessed at baseline and follow-up and include esthetic and functional appreciation, pain or discomfort. Radiographic assessments Intra-oral radiographs will be obtained prior to surgery (baseline) and at 1-, 3- and 5-year re-examinations. Analysis of radiographs will be performed by specialists in oral-maxillofacial radiology. The examiners will be blinded to treatment procedures. The assessment will include defect fill and crestal bone support. Power calculation A total of 122 patients (61 per group) will provide a power of 80% with alpha set at 0.05 to detect a difference of 1 mm in mean PPD change between groups, given a SD of 1.97 (Carcuac et al., 2016). 140 individuals will be included to compensate for drop-out. Data analysis Mean changes for the various variables and the proportion of sites fulfilling the criteria for treatment success will be calculated. A multilevel model with the clinical center as the highest level and the implant as the lowest will be built to test the influence of measured factors on the outcomes and to compensate for potential clustering of data. Data analysis including multilevel modeling will be conducted in collaboration with a biostatistician. Schedule of investigational events Screening and identification of subjects. Baseline clinical examination of implants selected for the study. Case presentation and reinforcement of self-performed plaque control. Assessment of PROM. Professional mechanical infection control. Radiographic examination prior to surgical therapy (within 4 weeks). Surgical therapy including test and control treatment procedures at study sites. 2 weeks - suture removal. Assessment of PROM. 6 weeks - professional supra-mucosal cleaning and reinforcement of oral hygiene. 6 months - clinical examination. 12 months - clinical and radiological examination. Assessment of PROM. 24 months - clinical examination. 36 months - clinical and radiological examination. Assessment of PROM. 48 months - clinical examination. 60 months - clinical and radiological examination. Assessment of PROM.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peri-Implantitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is designed as a two-arm randomized clinical trial.
Masking
Outcomes Assessor
Masking Description
Individuals assessing radiographic parameters will be masked to the intervention.
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control - Open flap debridement
Arm Type
Active Comparator
Arm Description
The surgical procedure includes flap elevation, debridement of the peri-implant defect and decontamination of the implant surfaces using saline for irrigation. Flaps are replaced in their original position and carefully sutured. Patients are provided with post-surgical information and thereafter called in for regular follow-up visits.
Arm Title
Test - Bone replacement graft
Arm Type
Experimental
Arm Description
The surgical procedure is identical to the control procedure with the exception of the application of the bone replacement graft. Following decontamination, Bio-Oss Collagen® is placed into the peri-implant bony defect. Flaps are carefully sutured and patients are provided with the same information and follow-up as patients in the control group.
Intervention Type
Procedure
Intervention Name(s)
Open flap debridement
Intervention Description
Open flap debridement using saline as irrigation
Intervention Type
Device
Intervention Name(s)
Bone replacement graft
Other Intervention Name(s)
Bio-Oss Collagen®
Intervention Description
Open flap debridement using saline as irrigation including a grafting procedure withBio-Oss Collagen®.
Primary Outcome Measure Information:
Title
Treatment success (year 1)
Description
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm recession of mucosal margin
Time Frame
Assessed at year 1
Title
Treatment success (year 3)
Description
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm recession of mucosal margin
Time Frame
Assessed at year 3
Title
Treatment success (year 5)
Description
Absence of bleeding/suppuration on probing, probing depth ≤5 mm and ≤1 mm
Time Frame
Assessed at year 5
Secondary Outcome Measure Information:
Title
Radiographic outcomes
Description
Defect fill and crestal bone support
Time Frame
Assessed at 1, 3 and 5 years
Title
Patient-reported outcomes
Description
Patient-reported outcomes assessed by questionnaire and in relation to baseline
Time Frame
Prior to intervention and at 1, 3 and 5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years ≥1 implant (≥1 year of function) presenting with PPD ≥7 mm and BoP/Pus. Confirmed bone loss ≥3 mm at same implant(s) Exclusion Criteria: Treated for peri-implantitis during previous 6 months Intake of systemic or local antibiotics during previous 6 months Systemic conditions affecting peri-implant tissues Systemic conditions impeding surgical intervention
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tord Berglundh, Professor
Organizational Affiliation
Göteborg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Periodontology, Institute of Odontology
City
Göteborg
ZIP/Postal Code
40530
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21092053
Citation
Albouy JP, Abrahamsson I, Persson LG, Berglundh T. Implant surface characteristics influence the outcome of treatment of peri-implantitis: an experimental study in dogs. J Clin Periodontol. 2011 Jan;38(1):58-64. doi: 10.1111/j.1600-051X.2010.01631.x. Epub 2010 Nov 24.
Results Reference
background
PubMed Identifier
25385434
Citation
Carcuac O, Abrahamsson I, Charalampakis G, Berglundh T. The effect of the local use of chlorhexidine in surgical treatment of experimental peri-implantitis in dogs. J Clin Periodontol. 2015 Feb;42(2):196-203. doi: 10.1111/jcpe.12332. Epub 2015 Jan 20.
Results Reference
background
PubMed Identifier
26285807
Citation
Carcuac O, Derks J, Charalampakis G, Abrahamsson I, Wennstrom J, Berglundh T. Adjunctive Systemic and Local Antimicrobial Therapy in the Surgical Treatment of Peri-implantitis: A Randomized Controlled Clinical Trial. J Dent Res. 2016 Jan;95(1):50-7. doi: 10.1177/0022034515601961. Epub 2015 Aug 18.
Results Reference
background
PubMed Identifier
26701919
Citation
Derks J, Schaller D, Hakansson J, Wennstrom JL, Tomasi C, Berglundh T. Effectiveness of Implant Therapy Analyzed in a Swedish Population: Prevalence of Peri-implantitis. J Dent Res. 2016 Jan;95(1):43-9. doi: 10.1177/0022034515608832.
Results Reference
background
PubMed Identifier
26450511
Citation
Jepsen K, Jepsen S, Laine ML, Anssari Moin D, Pilloni A, Zeza B, Sanz M, Ortiz-Vigon A, Roos-Jansaker AM, Renvert S. Reconstruction of Peri-implant Osseous Defects: A Multicenter Randomized Trial. J Dent Res. 2016 Jan;95(1):58-66. doi: 10.1177/0022034515610056. Epub 2015 Oct 8.
Results Reference
background
PubMed Identifier
24158331
Citation
Khoshkam V, Chan HL, Lin GH, MacEachern MP, Monje A, Suarez F, Giannobile WV, Wang HL. Reconstructive procedures for treating peri-implantitis: a systematic review. J Dent Res. 2013 Dec;92(12 Suppl):131S-8S. doi: 10.1177/0022034513509279. Epub 2013 Oct 24.
Results Reference
background
PubMed Identifier
26800389
Citation
Roccuzzo M, Gaudioso L, Lungo M, Dalmasso P. Surgical therapy of single peri-implantitis intrabony defects, by means of deproteinized bovine bone mineral with 10% collagen. J Clin Periodontol. 2016 Mar;43(3):311-8. doi: 10.1111/jcpe.12516. Epub 2016 Mar 9.
Results Reference
background
PubMed Identifier
22442781
Citation
Wohlfahrt JC, Lyngstadaas SP, Ronold HJ, Saxegaard E, Ellingsen JE, Karlsson S, Aass AM. Porous titanium granules in the surgical treatment of peri-implant osseous defects: a randomized clinical trial. Int J Oral Maxillofac Implants. 2012 Mar-Apr;27(2):401-10.
Results Reference
background

Learn more about this trial

Peri-implantitis - Reconstructive Surgical Therapy

We'll reach out to this number within 24 hrs